Association of previous schistosome infection with diabetes and metabolic syndrome: A cross-sectional study in rural China

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 2, 2013, Pages

  Chen, Yuhong ^a   Lu, Jieli ^a   Huang, Yun ^a   Wang, Tiange ^a   Xu, Yu ^a   Xu, Min ^a   Li, Mian ^a   Wang, Weiqing ^a   Li, Donghui ^b   Bi, Yufang ^a   Ning, Guang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BODY MASS; CHINA; CHINESE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; RURAL AREA; SCHISTOSOMIASIS; WAIST CIRCUMFERENCE;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BODY MASS INDEX; CHINA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RURAL POPULATION; SCHISTOSOMIASIS;

EID: 84874242531     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2517     Document Type: Article

References (19)

1. Wang Y, Holmes E, Nicholson JK, et al. Metabonomic investigations in mice infected with Schistosoma mansoni: an approach for biomarker identification. Proc Natl Acad Sci USA. 2004;101: 12676-12681.
2. Wu D, Molofsky AB, Liang HE, et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science. 2011;332:243-247.
3. Zaccone P, Fehervari Z, Jones FM, et al. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur J Immunol. 2003;33:1439-1449.
4. Thabet HS, Saleh NK, Thabet SS, Abdel-Aziz M, Kalleny NK. Decreased basal non-insulin-stimulated glucose uptake by diaphragm in streptozotocin-induced diabetic mice infected with Schistosoma mansoni. Parasitol Res. 2008;103:595-601.
5. Zaccone P, Burton O, Miller N, Jones FM, Dunne DW, Cooke A. Schistosoma mansoni egg antigens induce Treg that participate in diabetes prevention in NOD mice. Eur J Immunol. 2009;39:1098-1107.
6. Zaccone P, Burton OT, Gibbs S, et al. Immune modulation by Schistosoma mansoni antigens in NOD mice: effects on both innate and adaptive immune systems. J Biomed Biotechnol. doi: 10.1155/2010/795210.
7. Chinese Center for Disease Control and Prevention. http://www.ipd.org.cn.
8. Dexing Gui SW, Jie Qian, Li Cai. Prevalence survey on late stage schistosomiasis in Jiading district Shanghai. Shanghai J Prev Med. 2005;17(11):526-528.
9. Hü bner MP, Shi Y, Torrero MN, et al. Helminth protection against autoimmune diabetes in nonobese diabetic mice is independent of a type 2 immune shift and requires TGF-β. J Immunol. 15;2012; 188(2):559-568.
10. Aravindhan V, Mohan V, Surendar J, et al. Decreased prevalence of lymphatic filariasis among subjects with type-1 diabetes. AmJ Trop Med Hyg. 2010;83(6):1336-1339.
11. Kung WJ, Lin CC, Liu SH, Chaung HC. Association of interleukin-10 polymorphisms with cytokines in type 2 diabetic nephropathy. Diabetes Technol Ther. 2010;12:809-813.
12. Yang YS, Li XY, Hong J, et al. Interleukin-18 enhances glucose uptake in 3T3-L1 adipocytes. Endocrine. 2007;32:297-302.
13. Cavelti-Weder C, Furrer R, Keller C, et al. Inhibition of IL-1α improves fatigue in type 2 diabetes. Diabetes Care. 2011;34:e158.
14. Mooradian AD, Reed RL, Meredith KE, Scuderi P. Serum levels of tumor necrosis factor and IL-1α and IL-1α in diabetic patients. Diabetes Care. 1991;14:63-65.
15. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115:1111-1119.
16. Utzschneider KM, Kowdley KV. Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice. Nat Rev Endocrinol. 2010;6:26-33.
17. Cooksey RC, Jones D, Gabrielsen S, et al. Dietary iron restriction or iron chelation protects from diabetes and loss of β-cell function in the obese (ob/ob lep-/-) mouse. Am J Physiol Endocrinol Metab. 2010;298:E1236-E1243.
18. Manco M, Alisi A, Real JM, et al. Early interplay of intra-hepatic iron and insulin resistance in children with non-alcoholic fatty liver disease. J Hepatol. 2011;55:647-653.
19. Haap M, Machann J, von Friedeburg C, et al. Insulin sensitivity and liver fat: role of iron load. J Clin Endocrinol Metab. 2011;96:E958-E961.